Cornea/External Disease News

Reproxalap for the treatment of allergic conjunctivitis achieved the primary and secondary endpoints in the phase 3 INVIGORATE-2 clinical trial, according to a press release from Aldeyra Therapeutics.

A water-free cyclosporine solution showed efficacy in improving the signs and symptoms of dry eye disease in a randomized clinical trial.

Bausch + Lomb has unveiled two new products intended to mitigate contact lens dryness: a daily disposable multifocal lens and contact lens rehydrating drops inspired by natural tears.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Susan Benton and Darrell E. White, MD, provide an overview of the Preservative Freedom Coalition, which was recently launched by Thea Pharma.

The FDA approved Vevye, a 0.1% cyclosporine ophthalmic solution, for the treatment of signs and symptoms of dry eye disease, according to a press release from Novaliq.

KIAWAH ISLAND, S.C. — In this Healio Video Perspective from Kiawah Eye, Maggie Jeffries, MD, shares why Iheezo is a reliable ocular surface anesthetic option and gives tips on how to use it.

Glaukos completed enrollment in the second phase 3 confirmatory pivotal trial for Epioxa, its epi-on corneal cross-linking therapy, according to a press release.

SAN DIEGO — In this Healio Video Perspective from the ASCRS meeting, Preeya K. Gupta, MD, presents the results of the phase 2 trial of AZR-MD-001, an ointment for the treatment of meibomian gland dysfunction from Azura Ophthalmics.

Even if your practice is pressed for time, you have time to diagnose dry eye disease, treat it and track your results. Diagnosis doesn’t take a lot of extra equipment — just simple steps you can fit into a basic exam.

NEW ORLEANS — In this Healio Video Perspective from the ARVO meeting, Robert Herber, PhD, discusses a study that evaluated the detection of corneal ectasia using Anterion swept-source OCT from Heidelberg Engineering.